Germline genetic variants in ANGPT1 & 2 and FGF2 are associated with pathologic complete response to bevacizumab in breast cancer. Issam Makhoul, Robert Griffin, Stephen Erickson, Ishwori Dhakal, Venay R. Raj, Dorothy A. Graves, Jeannette Y. Lee, Mohammed S. Orloff, Eric R. Siegel, Susan A. Kadlubar. AACR Annual Meeting, April 5-9, San Diego.
Ethnic differences in CYP19A1 intronic SNPs and haplotype distributions among African American and Caucasian populations. Athena Starlard-Davenport, Ishwori Dhakal, Rosalind B. Penney, Mohammed Orloff, Susan Kadlubar. AACR Annual Meeting, April 5-9, San Diego.
Characterization of OLFML3 mutations in non-small cell lung cancer. Chelsea Drennan and Mohammed Orloff. Graduate Student Research Day, April 16, UAMS.
Characterization of OLFML3 mutations in non-small cell lung cancer: Expression of OLFML3 is affected by an altered immune environment in lung cancer cells. Chelsea Drennan, Rosalind B. Penny, and Mohammed Orloff. 64th Annual Meeting of the American Society of Human Genetics, Oct. 22, San Diego.
Investigation of CD36 mutations on phenotypic outcomes in patients with non-small cell lung cancer. Shamiso Ngongoni, Alison Harill and Mohammed Orloff. IMBRE, summer 2014, UAMS.